1 / 1

A Sneak Peek into the Professional Endeavors of Clark Swanson

Clark Swanson currently serves as the company's founder and co-chairman of Engineered Energy. He is also the founder of the consumer supplements holding company, Swanson Global Enterprises, Inc. Adding more to his professional endeavors, he is also the chairman and CEO of Swanson World Interactive Media ("SWIM"). He was also involved in the research and development of the novel cancer drug Caflanone.

Download Presentation

A Sneak Peek into the Professional Endeavors of Clark Swanson

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. A Sneak Peek into the Professional Endeavors of Clark Swanson Clark Swanson currently serves as the company's founder and co- chairman of Engineered Energy. He is a leader in the development of electric vehicle motor technology. He is also the founder of the consumer supplements holding company, Swanson Global Enterprises, Inc., which successfully surpassed a milestone of 1 million units sold. He is an American businessman who emphasizes consumer goods, new media, life sciences, cleantech, and energy. Adding more to his professional endeavors, he is also the chairman and CEO of Swanson World Interactive Media (“SWIM”), which owns and operates digital and print media publications focused on entertainment, fashion, and lifestyle brands. Swanson rose to fame in the mid-2000s as the co-founder and CEO of Blackline Safety, which was recognized as one of Canada's top 50 technological start- ups. It was under his direction that the business reached a valuation of around $500 million and won multiple awards, including IDC's "Top 10 to Watch," the TSX 50, Profit 500, and Deloitte's Fast 500. Clark Swanson was also involved in the research and development of the novel cancer drug Caflanone. This drug is known to inhibit pancreatic, brain, and blood cancers. He contributed to the development of novel SARS-Cov-2 therapeutics by co-authoring a patent, which served as the backbone for its development and testing. The scientific community recognized the efforts made by him and got them published in various medical journals. Clark earned an economics degree in 1995, furthering his education record. He then continued his studies at the Graziadio School of Business and Management to earn his Master of Business Administration.

More Related